Company to present at JP Morgan Healthcare conf

RNS Number : 7065X
Oxford Nanopore Technologies plc
07 January 2022
 

7 January 2022

 

Oxford Nanopore Technologies plc to present at the 40th Annual J.P. Morgan Healthcare Conference

Oxford Nanopore Technologies plc (the "Group"), the company behind a new generation of nanopore-based sensing technology, announces that the Group will be presenting virtually at the upcoming 40th Annual J.P. Morgan Healthcare Conference.

Dr Gordon Sanghera, Chief Executive Officer, and Tim Cowper, Chief Financial Officer, are scheduled to present on Tuesday, 11 January 2022 at 1500 Eastern Standard Time (2000 Greenwich Mean Time).

The presentation will be available on the Group's Investor website at https://nanoporetech.com/about-us/investors/reports .

 

For further information please contact:

Oxford Nanopore Technologies plc

Investors:    ir@nanoporetech.com

Media:    media@nanoporetech.com

Tulchan Group (communications adviser to the Company)

Tom Murray, Olivia Peters, Deborah Roney

+44 (0) 20 7353 4200  OxfordNanopore@tulchangroup.com  

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRADZGGMRVVGZZM
UK 100

Latest directors dealings